Acro Biomedical Co., Ltd.
ACBM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $42 | $42 | $60 | $60 |
| - Cash | $4 | $0 | $0 | $0 |
| + Debt | $0 | $255 | $166 | $152 |
| Enterprise Value | $38 | $297 | $226 | $212 |
| Revenue | $0 | $0 | $0 | -$360 |
| % Growth | – | – | 100% | – |
| Gross Profit | $0 | $0 | $0 | -$64 |
| % Margin | – | – | – | 17.8% |
| EBITDA | -$115 | -$14 | -$9 | -$9 |
| % Margin | – | – | – | 2.6% |
| Net Income | -$118 | -$16 | -$10 | -$11 |
| % Margin | – | – | – | 3% |
| EPS Diluted | -0.002 | -0 | -0 | 0.18 |
| % Growth | -566.7% | -50% | -100.1% | – |
| Operating Cash Flow | -$54 | -$94 | -$23 | -$23 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$54 | -$94 | -$23 | -$23 |